Ali, S. M., Hensing, T., Schrock, A. B., Allen, J., Sanford, E., Gowen, K., Kulkarni, A., He, J., Suh, J. H., Lipson, D., Elvin, J. A., Yelensky, R., Chalmers, Z., Chmielecki, J., Peled, N., Klempner, S. J., Firozvi, K., Frampton, G. M., Molina, J. R., Menon, S., Brahmer, J. R., MacMahon, H., Nowak, J., Ou, S. I., Zauderer, M., Ladanyi, M., Zakowski, M., Fischbach, N., Ross, J. S., Stephens, P. J., Miller, V. A., Wakelee, H., Ganesan, S., & Salgia, R. (2016). comprehensive Genomic Profiling Identifies a Subset of Crizotinib‐Responsive ALK‐Rearranged Non‐Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization. Oncologist, 21, 762–770. http://access.bl.uk/ark:/81055/vdc_100054383975.0x00002c